Wararka

Bishii Meey ee sanadkan, German PEI waxa ay daabacday maqaal "qiimaynta dareenka isbarbardhigga ee 122 CE-calaamadaha SARS-CoV-2 antigen-ka ee tijaabooyinka degdega ah", kaas oo qiimeeyay dareenka 122 COVID-19 antigen-ka alaabada tijaabada degdega ah ee hadda haysta shahaadooyinka CE lagu iibiyo Jarmalka..Sababo la xiriira isbeddelada xeerarka diiwaangelinta EU iyo siyaasadaha maaliyadeed ee Jarmalka, ujeedada qiimeynta isbarbardhigga waa in la xaqiijiyo dareenka alaabada hadda jirta.Reagen-yaasha aan buuxin shuruudaha ugu yar ee xasaasiga ah ayaa laga saaray liiska BfArM, iyo dhammaan natiijooyinka qiimaynta waa la siidaayay.Ku yaal bogga PEIQiimaynta waxaa ku jira 62 shirkadood oo Shiinees ah.

Tusaalaha diyaarinta: 3 gradients fiirsashada

U-fiirsashada aadka u sarreeya-PCR CT qiimaha 17-25

Feejignaanta sare-PCR CT qiimaha 25-30

Feejignaanta dhexdhexaadka ah-PCR CT qiimaha 30-36

Qiimaha CT iyo saamiga beddelka nuqulka RNA:

CT25 waxay ku saabsan tahay 10^6 koobiyo RNA/ml, CT30 waa qiyaastii 10^4 koobiyo RNA/ml, CT36na waxay ku saabsan tahay 10^3 koobiyo RNA/ml.

Heerka dareenka ugu yar:

Qiyaasta isku midka ah ee shaybaarada leh qiimaha PCR CT <25 waa 75%

Wax badan maaha in la yiraahdo, kaliya u tag xogta.

Natiijooyinka 1: Wadarta 96 alaab ayaa buuxiya shuruudaha ugu yar ee dareenka, kuwaas oo 48 ka mid ah ay yihiin alaabada Shiinaha.Si loo fududeeyo isbarbardhigga, natiijooyinka "CT17-36" waxaa loo kala soocaa mid sare ilaa hoose.

Natiijooyinka 2: Wadarta badeecadaha 26 ayaan buuxin shuruudaha ugu yar ee dareenka, kuwaas oo 14 ka mid ah ay yihiin alaabada Shiinaha.Si loo fududeeyo isbarbardhigga, natiijooyinka "CT17-36" waxaa loo kala soocaa mid sare ilaa hoose.

Isha macluumaadka: medRxiv preprint doi: Https://doi.org/10.1101/2021.05.11.21257016